| Literature DB >> 35320981 |
Michael S Deiner1,2, Gerami D Seitzman1,2, Gurbani Kaur3, Stephen D McLeod1,2, James Chodosh4, Thomas M Lietman1,2,5, Travis C Porco1,2,5.
Abstract
Background: In a prior study at the start of the pandemic, we reported reduced numbers of Google searches for the term "conjunctivitis" in the United States in March and April 2020 compared with prior years. As one explanation, we conjectured that reduced information-seeking may have resulted from social distancing reducing contagious conjunctivitis cases. Here, after 1 year of continued implementation of social distancing, we asked if there have been persistent reductions in searches for "conjunctivitis," and similarly for other communicable disease terms, compared to control terms. Objective: The aim of this study was to determine if reduction in searches in the United States for terms related to conjunctivitis and other common communicable diseases occurred in the spring-winter season of the COVID-19 pandemic, and to compare this outcome to searches for terms representing noncommunicable conditions, COVID-19, and to seasonality.Entities:
Keywords: COVID-19; Google Trends; communicable disease; conjunctivitis; influenza; infodemiology; information-seeking; ocular symptoms; online health information; pandemic; seasonality; social distancing; trend
Year: 2022 PMID: 35320981 PMCID: PMC8931841 DOI: 10.2196/31732
Source DB: PubMed Journal: JMIR Infodemiology ISSN: 2564-1891
Figure 1Search interest for COVID-19–related terms in 2020-2021 seasons compared to the same seasons in 2011-2019. In each panel, the x axis indicates week of the year and the y axis indicates weekly mean search interest values (Hampel-filtered and log-transformed for presentation purposes) for that term. Solid red, 2020 values; dashed red, 2021 values; gold, 2017-2019; green, 2014-2016; blue, 2011-2013. The 4 seasons are separated with vertical dashed lines. P values at the top of each panel for each season indicate if searches in that season of 2020-2021 were significantly (P<0.05) different overall (red, 2-sided test) than the same quarters in 2011-2019. Significant reductions are indicated by blue P values. Nonsignificant (P>.05) values are not shown. Seasonal characteristics for each term are shown as black text on the lower left of each panel. For terms with seasonality (P<.05), amplitude to mean ratios (AtM) are provided as an indicator of relative seasonal strength, as are circular mean week (Wk.) as an indicator of peak high season (assuming annual seasons); standard deviations are in parentheses.
Search interest for COVID-19–related terms in 2020-2021 seasons compared to the same seasons in 2011-2019 (related to Figure 1).
| Terms | Seasonalitya | ||||||||||||
|
| AtMd, mean (SD) | Weeke, circular mean (SD) | Spring | Summer | Autumn | Winter | Spring | Summer | Autumn | Winter | |||
| allergies | <.001 | 0.14 (0.05) | 19 (4.4) | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
| anosmia | .04 | 0.08 (0.06) | 7 (16.6) | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
| asthma | <.001 | 0.04 (0.04) | 5 (18.8) | <.001 | <.001 | .13 | .25 | >.99 | >.99 | .11 | .17 | ||
| coronavirus symptoms | >.99 | —f | — | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
| coronavirus test locations | >.99 | — | — | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
| dry cough | <.001 | 0.17 (0.06) | 3 (21.5) | <.001 | .009 | .33 | <.001 | >.99 | >.99 | .27 | <.001 | ||
| fever | <.001 | 0.14 (0.05) | 19 (4.4) | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
| flu | <.001 | 0.36 (0.05) | 52 (24.2) | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | <.001 | ||
| flu season | <.001 | 0.29 (0.08) | 0 (24.4) | <.001 | <.001 | .04 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
| headache | .22 | — | — | <.001 | .04 | .43 | .02 | >.99 | >.99 | >.99 | >.99 | ||
| influenza | <.001 | 0.38 (0.04) | 4 (1.2) | <.001 | <.001 | .10 | <.001 | >.99 | >.99 | >.99 | <.001 | ||
| my fever | .13 | — | — | .05 | .13 | .86 | <.001 | >.99 | >.99 | .66 | <.001 | ||
| problems breathing | >.99 | — | — | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
| shortness of breath | .43 | — | — | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
| why cant I smell | >.99 | — | — | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
| why cant I taste | .61 | — | — | <.001 | <.001 | <.001 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
aIndicates if the search for the years 2011-2019 shows a significant (P<.05) seasonal trend.
bTwo-sided P values regarding any change in search from prior years for each season.
cOne-sided P values regarding a decrease in search from prior years for each season.
dAtM: amplitude to mean ratio, indicating relative seasonal strength.
eIndicates peak high season.
fNot applicable; AtM and circular mean values are provided only for search terms where statistical evidence of that term being seasonal was found.
Figure 2Search interest for non-COVID-19, communicable, and noncommunicable terms in 2020-2021 seasons compared to the same seasons in 2011-2019. Time-series annual mean weekly search interest; P values indicating changes in 2020-2021 and seasonal values are all as described for Figure 1. Panel labels indicate communicable (shown first) and noncommunicable (shown second) classes that were compared group-wise using the Wilcoxon rank-sum test and Fisher exact test (described in the text and in Tables 2 and 3).
Search interest for non-COVID-19 communicable versus noncommunicable term groups in 2020-2021 seasons compared to those seasons in 2011-2019.
| Term | Seasonalitya | |||||||||||||
|
| AtMd, mean (SD) | Weeke, circular mean (SD) | Spring | Summer | Autumn | Winter | Spring | Summer | Autumn | Winter | ||||
|
| ||||||||||||||
|
| bug bite | <.001 | 0.38 (0.05) | 29 (1.2) | .54 | .43 | .06 | <.001 | .41 | >.99 | .05 | <.001 | ||
|
| chicken pox | .06 | —f | — | <.001 | <.001 | <.001 | <.001 | <.001 | .009 | <.001 | <.001 | ||
|
| chlamydia | .83 | — | — | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | ||
|
| cold medicine | <.001 | 0.25 (0.04) | 51 (21.6) | <.001 | .003 | <.001 | <.001 | <.001 | .004 | <.001 | <.001 | ||
|
| conjunctivitis | <.001 | 0.06 (0.04) | 13 (11) | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | ||
|
| ear infection | <.001 | 0.07 (0.05) | 4 (18.6) | <.001 | .05 | .001 | <.001 | <.001 | .05 | <.001 | <.001 | ||
|
| fifth disease | <.001 | 0.14 (0.06) | 11 (2.5) | <.001 | .03 | .02 | <.001 | <.001 | .03 | .02 | <.001 | ||
|
| german measles | .38 | — | — | .71 | .91 | .81 | .21 | .97 | .90 | .63 | .14 | ||
|
| gonorrhea | .48 | — | — | <.001 | .01 | <.001 | .02 | <.001 | .01 | <.001 | .01 | ||
|
| HIV | .05 | 0.02 (0.03) | 13 (14.8) | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | ||
|
| hpv | .62 | — | — | <.001 | .15 | .09 | <.001 | <.001 | .14 | .07 | <.001 | ||
|
| impetigo | .03 | 0.07 (0.06) | 35 (11) | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | ||
|
| lice | <.001 | 0.06 (0.05) | 35 (9.8) | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | ||
|
| measles | .01 | 0.23 (0.07) | 12 (3.6) | .10 | .01 | .06 | <.001 | .08 | .01 | .05 | <.001 | ||
|
| meningitis | .62 | — | — | <.001 | .008 | <.001 | <.001 | <.001 | .008 | <.001 | <.001 | ||
|
| mononucleosis | .25 | — | — | <.001 | .77 | .55 | <.001 | <.001 | .75 | .44 | <.001 | ||
|
| mumps | .62 | — | — | .01 | .004 | .002 | <.001 | .01 | .004 | .002 | <.001 | ||
|
| pertussis | .64 | — | — | <.001 | .84 | .36 | .003 | <.001 | >.99 | .28 | .002 | ||
|
| pink eye | <.001 | 0.09 (0.06) | 9 (17.4) | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | ||
|
| ringworm | <.001 | 0.03 (0.04) | 27 (10.6) | .04 | <.001 | <.001 | <.001 | .03 | <.001 | <.001 | <.001 | ||
|
| rubella | .01 | 0.05 (0.05) | 12 (14.5) | .15 | .69 | .79 | .01 | .12 | .65 | .62 | .008 | ||
|
| salmonella | .62 | — | — | .25 | .45 | .43 | <.001 | .20 | >.99 | .35 | <.001 | ||
|
| scabies | .11 | — | — | <.001 | .02 | <.001 | <.001 | <.001 | .02 | <.001 | <.001 | ||
|
| shingles treatment | .19 | — | — | .15 | .47 | .33 | .93 | >.99 | >.99 | >.99 | .62 | ||
|
| std | .02 | 0.01 (0.03) | 20 (15.9) | <.001 | <.001 | .005 | <.001 | <.001 | <.001 | .004 | <.001 | ||
|
| stomach flu | <.001 | 0.33 (0.06) | 3 (1.2) | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | ||
|
| strep throat | <.001 | 0.12 (0.07) | 5 (19.9) | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | <.001 | ||
|
| syphilis | .88 | — | — | .22 | .81 | .36 | .93 | .17 | .78 | .29 | .70 | ||
|
| tuberculosis | .05 | — | — | .53 | .04 | .74 | .02 | .40 | >.99 | .60 | .02 | ||
|
| ||||||||||||||
|
| arthritis | .26 | — | — | <.001 | .33 | .65 | .07 | <.001 | >.99 | >.99 | .05 | ||
|
| broken bone | .23 | — | — | <.001 | .03 | .53 | .004 | <.001 | .03 | .43 | .003 | ||
|
| burning eyes | >.99 | — | — | <.001 | .002 | .04 | <.001 | >.99 | >.99 | >.99 | >.99 | ||
|
| cancer | .26 | — | — | <.001 | <.001 | .007 | <.001 | <.001 | <.001 | .006 | <.001 | ||
|
| cataracts | .97 | — | — | <.001 | .33 | .50 | .12 | <.001 | .30 | .41 | .08 | ||
|
| claritin | <.001 | 0.16 (0.06) | 18 (3.2) | .50 | .63 | .59 | .002 | .39 | >.99 | .46 | .002 | ||
|
| corneal ulcer | .26 | — | — | .10 | .04 | .74 | .86 | .08 | .03 | .60 | .56 | ||
|
| diabetes | .01 | 0.02 (0.05) | 6 (18.9) | <.001 | .84 | .20 | .93 | <.001 | >.99 | .16 | .70 | ||
|
| diabetic retinopathy | .88 | — | — | .15 | .70 | .43 | .40 | .12 | >.99 | >.99 | .26 | ||
|
| dry eyes | .13 | — | — | .02 | .93 | .04 | <.001 | .02 | >.99 | >.99 | >.99 | ||
|
| eczema | <.001 | 0.04 (0.05) | 9 (17.2) | .30 | .19 | .04 | .003 | .24 | .18 | .03 | .002 | ||
|
| glaucoma | .41 | — | — | <.001 | .42 | .36 | .03 | <.001 | .38 | .29 | .02 | ||
|
| heart attack | .01 | 0.04 (0.06) | 12 (10) | .15 | .41 | .34 | .03 | .12 | .37 | .28 | .02 | ||
|
| high blood pressure | <.001 | 0.05 (0.04) | 5 (13.2) | <.001 | .91 | .66 | .29 | <001 | .89 | >.99 | .20 | ||
|
| itchy eyes | <.001 | 0.1 (0.05) | 18 (5.3) | <.001 | .003 | .10 | .22 | >.99 | >.99 | >.99 | >.99 | ||
|
| macular degeneration | .78 | — | — | <.001 | .42 | .36 | .08 | <.001 | >.99 | >.99 | .05 | ||
|
| memory loss | .92 | — | — | <.001 | .81 | .79 | .93 | <.001 | >.99 | .62 | .71 | ||
|
| pollen | <.001 | 0.29 (0.07) | 17 (1.7) | <.001 | <.001 | <.001 | .28 | >.99 | >.99 | >.99 | >.99 | ||
|
| pregnant | .05 | — | — | .38 | .43 | .79 | .80 | .30 | .38 | .62 | .53 | ||
|
| red eyes | .19 | — | — | .004 | .72 | .86 | .59 | >.99 | >.99 | .66 | .39 | ||
|
| sore eyes | .83 | — | — | .51 | .22 | .04 | .12 | .39 | >.99 | >.99 | >.99 | ||
|
| stroke symptoms | <.001 | 0.09 (0.04) | 26 (8) | .25 | .91 | .36 | .06 | >.99 | >.99 | >.99 | >.99 | ||
|
| toothache | .62 | — | — | .06 | .41 | .13 | .34 | >.99 | .37 | .11 | .23 | ||
aIndicates if the search for the years 2011-2019 shows a significant (P<.05) seasonal trend.
bTwo-sided P values regarding any change in search from prior years for each season.
cOne-sided P values regarding a decrease in search from prior years for each season.
dAtM: amplitude to mean ratio, indicating relative seasonal strength.
eIndicates peak high season.
fNot applicable; AtM and circular mean values are provided only for search terms where statistical evidence of that term being seasonal was found.
Comparison of the differences and reductions in search postpandemic (P values in Table 2), for communicable vs noncommunicable condition search terms groups, by season.
| Season | Difference from prior yearsa | Search lower than prior yearsb | ||
|
| Wilcoxon rank-sum test | Fisher exact test | Wilcoxon rank-sum test | Fisher exact test |
| Spring | .99 | .83 | .04 | .09 |
| Summer | .05 | .01 | <.001 | <.001 |
| Autumn | .02 | .01 | <.001 | <.001 |
| Winter | <.001 | .003 | <.001 | <.001 |
aP values when testing if significant changes in search after the start of the pandemic differed for the communicable and noncommunicable classifications of non-COVID-19 term groups.
bP values when testing if significant reductions in search after the start of the pandemic differed for the communicable and noncommunicable classifications of non-COVID-19 term groups.